0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hot Flashes Treatment Market Research Report 2023
Published Date: October 2023
|
Report Code: QYRE-Auto-7S12744
Home | Market Reports | Health| Pharmacy
Global Hot Flashes Treatment Market Research Report 2022
BUY CHAPTERS

Global Hot Flashes Treatment Market Research Report 2023

Code: QYRE-Auto-7S12744
Report
October 2023
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hot Flashes Treatment Market Size

According to new survey, global Hot Flashes Treatment market is projected to reach US$ 15520 million in 2029, increasing from US$ 12200 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029.

Hot Flashes Treatment Market

Hot Flashes Treatment Market

Hot flashes are typically characterized by sudden mild or intense body heat because of the changes occurrence by hormones. This occurs due to decreased level of estrogens. The phenomenon of host flashes in men, young women, or pregnant ladies is projected because of medical conditions that may also disrupt the body’s ability to regulate temperature. It is mostly seen in menopause conditions. The hot flashes are generally belief to be lasting for 30 minutes. The common symptoms associated with hot flashes include feeling of anxiety, rapid heartbeat, perspiration on upper body, red and blotchy skin and palpitations.
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hot Flashes Treatment market research.
Factors such as rising incidence of vasomotor symptoms during menopause and technological advancements in developing new therapeutic agents are driving the market growth. For example, according to an article published in the June 2022 issue of Women's Health, an online survey was conducted in the United Kingdom between 19 and 26 May 2021 to assess attitudes, years of knowledge and symptoms. According to observations, 68.9% of women experienced mood swings during menopause, 68.3% experienced brain fog, and 66.8% experienced fatigue symptoms. In addition, other psychological problems, including irritability, poor concentration, poor memory, lack of motivation, decreased self-confidence and anxiety, can affect their quality of life.
According to an article published in September 2021 in the International Journal of Reproductive Biomedicine, it has been observed that around 50-85% of women worldwide experience menopausal heat symptoms. Furthermore, according to the same source, the prevalence of menopausal hot flash symptoms is reported to be highest in Western countries and lowest in Asian countries. This is expected to spur the demand for hormonal and non-hormonal therapies for the treatment of menopausal symptoms, thereby boosting the market growth.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hot Flashes Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Hot Flashes Treatment Market Report

Report Metric Details
Report Name Hot Flashes Treatment Market
Accounted market size in 2022 US$ 12200 in million
Forecasted market size in 2029 US$ 15520 million
CAGR 3.5%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Oral
  • Parenteral
Segment by Application
  • Hospital
  • Specialist Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie Inc, Bausch Health Companies Inc, Teva Pharmaceutical Industries Ltd, Cipla Inc, Lupin, Sun Pharmaceuticals Industries Ltd, Hikma Pharmaceuticals PLC, Boehringer Ingelheim International GmbH, Sanofi, AstraZeneca, GSK Plc, Pfizer Inc, Novartis AG, Mylan N.V, Hisamitsu Pharmaceutical Co.,Inc, Merck & Co., Inc, TherapeuticsMD, Inc, Lilly, Emcure Pharmaceuticals Limited, Bayer AG, Novo Nordisk Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Hot Flashes Treatment Market growing?

Ans: The Hot Flashes Treatment Market witnessing a CAGR of 3.5% during the forecast period 2023-2029.

What is the Hot Flashes Treatment Market size in 2029?

Ans: The Hot Flashes Treatment Market size in 2029 will be US$ 15520 million.

Who are the main players in the Hot Flashes Treatment Market report?

Ans: The main players in the Hot Flashes Treatment Market are AbbVie Inc, Bausch Health Companies Inc, Teva Pharmaceutical Industries Ltd, Cipla Inc, Lupin, Sun Pharmaceuticals Industries Ltd, Hikma Pharmaceuticals PLC, Boehringer Ingelheim International GmbH, Sanofi, AstraZeneca, GSK Plc, Pfizer Inc, Novartis AG, Mylan N.V, Hisamitsu Pharmaceutical Co.,Inc, Merck & Co., Inc, TherapeuticsMD, Inc, Lilly, Emcure Pharmaceuticals Limited, Bayer AG, Novo Nordisk Corporation

What are the Application segmentation covered in the Hot Flashes Treatment Market report?

Ans: The Applications covered in the Hot Flashes Treatment Market report are Hospital, Specialist Clinic, Other

What are the Type segmentation covered in the Hot Flashes Treatment Market report?

Ans: The Types covered in the Hot Flashes Treatment Market report are Oral, Parenteral

1 Hot Flashes Treatment Market Overview
1.1 Product Overview and Scope of Hot Flashes Treatment
1.2 Hot Flashes Treatment Segment by Type
1.2.1 Global Hot Flashes Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Parenteral
1.3 Hot Flashes Treatment Segment by Application
1.3.1 Global Hot Flashes Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Other
1.4 Global Hot Flashes Treatment Market Size Estimates and Forecasts
1.4.1 Global Hot Flashes Treatment Revenue 2018-2029
1.4.2 Global Hot Flashes Treatment Sales 2018-2029
1.4.3 Global Hot Flashes Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hot Flashes Treatment Market Competition by Manufacturers
2.1 Global Hot Flashes Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hot Flashes Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hot Flashes Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Hot Flashes Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hot Flashes Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hot Flashes Treatment, Product Type & Application
2.7 Hot Flashes Treatment Market Competitive Situation and Trends
2.7.1 Hot Flashes Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hot Flashes Treatment Players Market Share by Revenue
2.7.3 Global Hot Flashes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hot Flashes Treatment Retrospective Market Scenario by Region
3.1 Global Hot Flashes Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hot Flashes Treatment Global Hot Flashes Treatment Sales by Region: 2018-2029
3.2.1 Global Hot Flashes Treatment Sales by Region: 2018-2023
3.2.2 Global Hot Flashes Treatment Sales by Region: 2024-2029
3.3 Global Hot Flashes Treatment Global Hot Flashes Treatment Revenue by Region: 2018-2029
3.3.1 Global Hot Flashes Treatment Revenue by Region: 2018-2023
3.3.2 Global Hot Flashes Treatment Revenue by Region: 2024-2029
3.4 North America Hot Flashes Treatment Market Facts & Figures by Country
3.4.1 North America Hot Flashes Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hot Flashes Treatment Sales by Country (2018-2029)
3.4.3 North America Hot Flashes Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hot Flashes Treatment Market Facts & Figures by Country
3.5.1 Europe Hot Flashes Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hot Flashes Treatment Sales by Country (2018-2029)
3.5.3 Europe Hot Flashes Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hot Flashes Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Hot Flashes Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hot Flashes Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Hot Flashes Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hot Flashes Treatment Market Facts & Figures by Country
3.7.1 Latin America Hot Flashes Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hot Flashes Treatment Sales by Country (2018-2029)
3.7.3 Latin America Hot Flashes Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hot Flashes Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Hot Flashes Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hot Flashes Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hot Flashes Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hot Flashes Treatment Sales by Type (2018-2029)
4.1.1 Global Hot Flashes Treatment Sales by Type (2018-2023)
4.1.2 Global Hot Flashes Treatment Sales by Type (2024-2029)
4.1.3 Global Hot Flashes Treatment Sales Market Share by Type (2018-2029)
4.2 Global Hot Flashes Treatment Revenue by Type (2018-2029)
4.2.1 Global Hot Flashes Treatment Revenue by Type (2018-2023)
4.2.2 Global Hot Flashes Treatment Revenue by Type (2024-2029)
4.2.3 Global Hot Flashes Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Hot Flashes Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Hot Flashes Treatment Sales by Application (2018-2029)
5.1.1 Global Hot Flashes Treatment Sales by Application (2018-2023)
5.1.2 Global Hot Flashes Treatment Sales by Application (2024-2029)
5.1.3 Global Hot Flashes Treatment Sales Market Share by Application (2018-2029)
5.2 Global Hot Flashes Treatment Revenue by Application (2018-2029)
5.2.1 Global Hot Flashes Treatment Revenue by Application (2018-2023)
5.2.2 Global Hot Flashes Treatment Revenue by Application (2024-2029)
5.2.3 Global Hot Flashes Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Hot Flashes Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Corporation Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Inc Hot Flashes Treatment Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Bausch Health Companies Inc
6.2.1 Bausch Health Companies Inc Corporation Information
6.2.2 Bausch Health Companies Inc Description and Business Overview
6.2.3 Bausch Health Companies Inc Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bausch Health Companies Inc Hot Flashes Treatment Product Portfolio
6.2.5 Bausch Health Companies Inc Recent Developments/Updates
6.3 Teva Pharmaceutical Industries Ltd
6.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.3.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Pharmaceutical Industries Ltd Hot Flashes Treatment Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.4 Cipla Inc
6.4.1 Cipla Inc Corporation Information
6.4.2 Cipla Inc Description and Business Overview
6.4.3 Cipla Inc Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Inc Hot Flashes Treatment Product Portfolio
6.4.5 Cipla Inc Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Corporation Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lupin Hot Flashes Treatment Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Sun Pharmaceuticals Industries Ltd
6.6.1 Sun Pharmaceuticals Industries Ltd Corporation Information
6.6.2 Sun Pharmaceuticals Industries Ltd Description and Business Overview
6.6.3 Sun Pharmaceuticals Industries Ltd Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sun Pharmaceuticals Industries Ltd Hot Flashes Treatment Product Portfolio
6.6.5 Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
6.7 Hikma Pharmaceuticals PLC
6.6.1 Hikma Pharmaceuticals PLC Corporation Information
6.6.2 Hikma Pharmaceuticals PLC Description and Business Overview
6.6.3 Hikma Pharmaceuticals PLC Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hikma Pharmaceuticals PLC Hot Flashes Treatment Product Portfolio
6.7.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
6.8 Boehringer Ingelheim International GmbH
6.8.1 Boehringer Ingelheim International GmbH Corporation Information
6.8.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.8.3 Boehringer Ingelheim International GmbH Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Boehringer Ingelheim International GmbH Hot Flashes Treatment Product Portfolio
6.8.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sanofi Hot Flashes Treatment Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AstraZeneca Hot Flashes Treatment Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 GSK Plc
6.11.1 GSK Plc Corporation Information
6.11.2 GSK Plc Hot Flashes Treatment Description and Business Overview
6.11.3 GSK Plc Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 GSK Plc Hot Flashes Treatment Product Portfolio
6.11.5 GSK Plc Recent Developments/Updates
6.12 Pfizer Inc
6.12.1 Pfizer Inc Corporation Information
6.12.2 Pfizer Inc Hot Flashes Treatment Description and Business Overview
6.12.3 Pfizer Inc Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Pfizer Inc Hot Flashes Treatment Product Portfolio
6.12.5 Pfizer Inc Recent Developments/Updates
6.13 Novartis AG
6.13.1 Novartis AG Corporation Information
6.13.2 Novartis AG Hot Flashes Treatment Description and Business Overview
6.13.3 Novartis AG Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Novartis AG Hot Flashes Treatment Product Portfolio
6.13.5 Novartis AG Recent Developments/Updates
6.14 Mylan N.V
6.14.1 Mylan N.V Corporation Information
6.14.2 Mylan N.V Hot Flashes Treatment Description and Business Overview
6.14.3 Mylan N.V Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Mylan N.V Hot Flashes Treatment Product Portfolio
6.14.5 Mylan N.V Recent Developments/Updates
6.15 Hisamitsu Pharmaceutical Co.,Inc
6.15.1 Hisamitsu Pharmaceutical Co.,Inc Corporation Information
6.15.2 Hisamitsu Pharmaceutical Co.,Inc Hot Flashes Treatment Description and Business Overview
6.15.3 Hisamitsu Pharmaceutical Co.,Inc Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Hisamitsu Pharmaceutical Co.,Inc Hot Flashes Treatment Product Portfolio
6.15.5 Hisamitsu Pharmaceutical Co.,Inc Recent Developments/Updates
6.16 Merck & Co., Inc
6.16.1 Merck & Co., Inc Corporation Information
6.16.2 Merck & Co., Inc Hot Flashes Treatment Description and Business Overview
6.16.3 Merck & Co., Inc Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Merck & Co., Inc Hot Flashes Treatment Product Portfolio
6.16.5 Merck & Co., Inc Recent Developments/Updates
6.17 TherapeuticsMD, Inc
6.17.1 TherapeuticsMD, Inc Corporation Information
6.17.2 TherapeuticsMD, Inc Hot Flashes Treatment Description and Business Overview
6.17.3 TherapeuticsMD, Inc Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.17.4 TherapeuticsMD, Inc Hot Flashes Treatment Product Portfolio
6.17.5 TherapeuticsMD, Inc Recent Developments/Updates
6.18 Lilly
6.18.1 Lilly Corporation Information
6.18.2 Lilly Hot Flashes Treatment Description and Business Overview
6.18.3 Lilly Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Lilly Hot Flashes Treatment Product Portfolio
6.18.5 Lilly Recent Developments/Updates
6.19 Emcure Pharmaceuticals Limited
6.19.1 Emcure Pharmaceuticals Limited Corporation Information
6.19.2 Emcure Pharmaceuticals Limited Hot Flashes Treatment Description and Business Overview
6.19.3 Emcure Pharmaceuticals Limited Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Emcure Pharmaceuticals Limited Hot Flashes Treatment Product Portfolio
6.19.5 Emcure Pharmaceuticals Limited Recent Developments/Updates
6.20 Bayer AG
6.20.1 Bayer AG Corporation Information
6.20.2 Bayer AG Hot Flashes Treatment Description and Business Overview
6.20.3 Bayer AG Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Bayer AG Hot Flashes Treatment Product Portfolio
6.20.5 Bayer AG Recent Developments/Updates
6.21 Novo Nordisk Corporation
6.21.1 Novo Nordisk Corporation Corporation Information
6.21.2 Novo Nordisk Corporation Hot Flashes Treatment Description and Business Overview
6.21.3 Novo Nordisk Corporation Hot Flashes Treatment Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Novo Nordisk Corporation Hot Flashes Treatment Product Portfolio
6.21.5 Novo Nordisk Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hot Flashes Treatment Industry Chain Analysis
7.2 Hot Flashes Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hot Flashes Treatment Production Mode & Process
7.4 Hot Flashes Treatment Sales and Marketing
7.4.1 Hot Flashes Treatment Sales Channels
7.4.2 Hot Flashes Treatment Distributors
7.5 Hot Flashes Treatment Customers
8 Hot Flashes Treatment Market Dynamics
8.1 Hot Flashes Treatment Industry Trends
8.2 Hot Flashes Treatment Market Drivers
8.3 Hot Flashes Treatment Market Challenges
8.4 Hot Flashes Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Hot Flashes Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Hot Flashes Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Hot Flashes Treatment Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Hot Flashes Treatment Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Hot Flashes Treatment Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Hot Flashes Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Hot Flashes Treatment Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Hot Flashes Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Hot Flashes Treatment, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Hot Flashes Treatment, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Hot Flashes Treatment, Product Type & Application
    Table 12. Global Key Manufacturers of Hot Flashes Treatment, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Hot Flashes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hot Flashes Treatment as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Hot Flashes Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Hot Flashes Treatment Sales by Region (2018-2023) & (K Units)
    Table 18. Global Hot Flashes Treatment Sales Market Share by Region (2018-2023)
    Table 19. Global Hot Flashes Treatment Sales by Region (2024-2029) & (K Units)
    Table 20. Global Hot Flashes Treatment Sales Market Share by Region (2024-2029)
    Table 21. Global Hot Flashes Treatment Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Hot Flashes Treatment Revenue Market Share by Region (2018-2023)
    Table 23. Global Hot Flashes Treatment Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Hot Flashes Treatment Revenue Market Share by Region (2024-2029)
    Table 25. North America Hot Flashes Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Hot Flashes Treatment Sales by Country (2018-2023) & (K Units)
    Table 27. North America Hot Flashes Treatment Sales by Country (2024-2029) & (K Units)
    Table 28. North America Hot Flashes Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Hot Flashes Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Hot Flashes Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Hot Flashes Treatment Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Hot Flashes Treatment Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Hot Flashes Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Hot Flashes Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Hot Flashes Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Hot Flashes Treatment Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Hot Flashes Treatment Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Hot Flashes Treatment Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Hot Flashes Treatment Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Hot Flashes Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Hot Flashes Treatment Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Hot Flashes Treatment Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Hot Flashes Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Hot Flashes Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Hot Flashes Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Hot Flashes Treatment Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Hot Flashes Treatment Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Hot Flashes Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Hot Flashes Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Hot Flashes Treatment Sales (K Units) by Type (2018-2023)
    Table 51. Global Hot Flashes Treatment Sales (K Units) by Type (2024-2029)
    Table 52. Global Hot Flashes Treatment Sales Market Share by Type (2018-2023)
    Table 53. Global Hot Flashes Treatment Sales Market Share by Type (2024-2029)
    Table 54. Global Hot Flashes Treatment Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Hot Flashes Treatment Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Hot Flashes Treatment Revenue Market Share by Type (2018-2023)
    Table 57. Global Hot Flashes Treatment Revenue Market Share by Type (2024-2029)
    Table 58. Global Hot Flashes Treatment Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Hot Flashes Treatment Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Hot Flashes Treatment Sales (K Units) by Application (2018-2023)
    Table 61. Global Hot Flashes Treatment Sales (K Units) by Application (2024-2029)
    Table 62. Global Hot Flashes Treatment Sales Market Share by Application (2018-2023)
    Table 63. Global Hot Flashes Treatment Sales Market Share by Application (2024-2029)
    Table 64. Global Hot Flashes Treatment Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Hot Flashes Treatment Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Hot Flashes Treatment Revenue Market Share by Application (2018-2023)
    Table 67. Global Hot Flashes Treatment Revenue Market Share by Application (2024-2029)
    Table 68. Global Hot Flashes Treatment Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Hot Flashes Treatment Price (US$/Unit) by Application (2024-2029)
    Table 70. AbbVie Inc Corporation Information
    Table 71. AbbVie Inc Description and Business Overview
    Table 72. AbbVie Inc Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. AbbVie Inc Hot Flashes Treatment Product
    Table 74. AbbVie Inc Recent Developments/Updates
    Table 75. Bausch Health Companies Inc Corporation Information
    Table 76. Bausch Health Companies Inc Description and Business Overview
    Table 77. Bausch Health Companies Inc Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Bausch Health Companies Inc Hot Flashes Treatment Product
    Table 79. Bausch Health Companies Inc Recent Developments/Updates
    Table 80. Teva Pharmaceutical Industries Ltd Corporation Information
    Table 81. Teva Pharmaceutical Industries Ltd Description and Business Overview
    Table 82. Teva Pharmaceutical Industries Ltd Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Teva Pharmaceutical Industries Ltd Hot Flashes Treatment Product
    Table 84. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
    Table 85. Cipla Inc Corporation Information
    Table 86. Cipla Inc Description and Business Overview
    Table 87. Cipla Inc Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Cipla Inc Hot Flashes Treatment Product
    Table 89. Cipla Inc Recent Developments/Updates
    Table 90. Lupin Corporation Information
    Table 91. Lupin Description and Business Overview
    Table 92. Lupin Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Lupin Hot Flashes Treatment Product
    Table 94. Lupin Recent Developments/Updates
    Table 95. Sun Pharmaceuticals Industries Ltd Corporation Information
    Table 96. Sun Pharmaceuticals Industries Ltd Description and Business Overview
    Table 97. Sun Pharmaceuticals Industries Ltd Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Sun Pharmaceuticals Industries Ltd Hot Flashes Treatment Product
    Table 99. Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
    Table 100. Hikma Pharmaceuticals PLC Corporation Information
    Table 101. Hikma Pharmaceuticals PLC Description and Business Overview
    Table 102. Hikma Pharmaceuticals PLC Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Hikma Pharmaceuticals PLC Hot Flashes Treatment Product
    Table 104. Hikma Pharmaceuticals PLC Recent Developments/Updates
    Table 105. Boehringer Ingelheim International GmbH Corporation Information
    Table 106. Boehringer Ingelheim International GmbH Description and Business Overview
    Table 107. Boehringer Ingelheim International GmbH Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Boehringer Ingelheim International GmbH Hot Flashes Treatment Product
    Table 109. Boehringer Ingelheim International GmbH Recent Developments/Updates
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Business Overview
    Table 112. Sanofi Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Sanofi Hot Flashes Treatment Product
    Table 114. Sanofi Recent Developments/Updates
    Table 115. AstraZeneca Corporation Information
    Table 116. AstraZeneca Description and Business Overview
    Table 117. AstraZeneca Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. AstraZeneca Hot Flashes Treatment Product
    Table 119. AstraZeneca Recent Developments/Updates
    Table 120. GSK Plc Corporation Information
    Table 121. GSK Plc Description and Business Overview
    Table 122. GSK Plc Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. GSK Plc Hot Flashes Treatment Product
    Table 124. GSK Plc Recent Developments/Updates
    Table 125. Pfizer Inc Corporation Information
    Table 126. Pfizer Inc Description and Business Overview
    Table 127. Pfizer Inc Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. Pfizer Inc Hot Flashes Treatment Product
    Table 129. Pfizer Inc Recent Developments/Updates
    Table 130. Novartis AG Corporation Information
    Table 131. Novartis AG Description and Business Overview
    Table 132. Novartis AG Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 133. Novartis AG Hot Flashes Treatment Product
    Table 134. Novartis AG Recent Developments/Updates
    Table 135. Mylan N.V Corporation Information
    Table 136. Mylan N.V Description and Business Overview
    Table 137. Mylan N.V Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 138. Mylan N.V Hot Flashes Treatment Product
    Table 139. Mylan N.V Recent Developments/Updates
    Table 140. Hisamitsu Pharmaceutical Co.,Inc Corporation Information
    Table 141. Hisamitsu Pharmaceutical Co.,Inc Description and Business Overview
    Table 142. Hisamitsu Pharmaceutical Co.,Inc Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 143. Hisamitsu Pharmaceutical Co.,Inc Hot Flashes Treatment Product
    Table 144. Hisamitsu Pharmaceutical Co.,Inc Recent Developments/Updates
    Table 145. Merck & Co., Inc Corporation Information
    Table 146. Merck & Co., Inc Description and Business Overview
    Table 147. Merck & Co., Inc Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 148. Merck & Co., Inc Hot Flashes Treatment Product
    Table 149. Merck & Co., Inc Recent Developments/Updates
    Table 150. TherapeuticsMD, Inc Corporation Information
    Table 151. TherapeuticsMD, Inc Description and Business Overview
    Table 152. TherapeuticsMD, Inc Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 153. TherapeuticsMD, Inc Hot Flashes Treatment Product
    Table 154. TherapeuticsMD, Inc Recent Developments/Updates
    Table 155. Lilly Corporation Information
    Table 156. Lilly Description and Business Overview
    Table 157. Lilly Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 158. Lilly Hot Flashes Treatment Product
    Table 159. Lilly Recent Developments/Updates
    Table 160. Emcure Pharmaceuticals Limited Corporation Information
    Table 161. Emcure Pharmaceuticals Limited Description and Business Overview
    Table 162. Emcure Pharmaceuticals Limited Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 163. Emcure Pharmaceuticals Limited Hot Flashes Treatment Product
    Table 164. Emcure Pharmaceuticals Limited Recent Developments/Updates
    Table 165. Bayer AG Corporation Information
    Table 166. Bayer AG Description and Business Overview
    Table 167. Bayer AG Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 168. Bayer AG Hot Flashes Treatment Product
    Table 169. Bayer AG Recent Developments/Updates
    Table 170. Novo Nordisk Corporation Corporation Information
    Table 171. Novo Nordisk Corporation Description and Business Overview
    Table 172. Novo Nordisk Corporation Hot Flashes Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 173. Novo Nordisk Corporation Hot Flashes Treatment Product
    Table 174. Novo Nordisk Corporation Recent Developments/Updates
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Hot Flashes Treatment Distributors List
    Table 178. Hot Flashes Treatment Customers List
    Table 179. Hot Flashes Treatment Market Trends
    Table 180. Hot Flashes Treatment Market Drivers
    Table 181. Hot Flashes Treatment Market Challenges
    Table 182. Hot Flashes Treatment Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Hot Flashes Treatment
    Figure 2. Global Hot Flashes Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Hot Flashes Treatment Market Share by Type in 2022 & 2029
    Figure 4. Oral Product Picture
    Figure 5. Parenteral Product Picture
    Figure 6. Global Hot Flashes Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Hot Flashes Treatment Market Share by Application in 2022 & 2029
    Figure 8. Hospital
    Figure 9. Specialist Clinic
    Figure 10. Other
    Figure 11. Global Hot Flashes Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Hot Flashes Treatment Market Size (2018-2029) & (US$ Million)
    Figure 13. Global Hot Flashes Treatment Sales (2018-2029) & (K Units)
    Figure 14. Global Hot Flashes Treatment Average Price (US$/Unit) & (2018-2029)
    Figure 15. Hot Flashes Treatment Report Years Considered
    Figure 16. Hot Flashes Treatment Sales Share by Manufacturers in 2022
    Figure 17. Global Hot Flashes Treatment Revenue Share by Manufacturers in 2022
    Figure 18. The Global 5 and 10 Largest Hot Flashes Treatment Players: Market Share by Revenue in 2022
    Figure 19. Hot Flashes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 20. Global Hot Flashes Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 21. North America Hot Flashes Treatment Sales Market Share by Country (2018-2029)
    Figure 22. North America Hot Flashes Treatment Revenue Market Share by Country (2018-2029)
    Figure 23. United States Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Canada Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Europe Hot Flashes Treatment Sales Market Share by Country (2018-2029)
    Figure 26. Europe Hot Flashes Treatment Revenue Market Share by Country (2018-2029)
    Figure 27. Germany Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. France Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. U.K. Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Italy Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Russia Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Asia Pacific Hot Flashes Treatment Sales Market Share by Region (2018-2029)
    Figure 33. Asia Pacific Hot Flashes Treatment Revenue Market Share by Region (2018-2029)
    Figure 34. China Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Japan Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. South Korea Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. India Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Australia Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. China Taiwan Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Southeast Asia Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Latin America Hot Flashes Treatment Sales Market Share by Country (2018-2029)
    Figure 42. Latin America Hot Flashes Treatment Revenue Market Share by Country (2018-2029)
    Figure 43. Mexico Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Brazil Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Argentina Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Hot Flashes Treatment Sales Market Share by Country (2018-2029)
    Figure 47. Middle East & Africa Hot Flashes Treatment Revenue Market Share by Country (2018-2029)
    Figure 48. Turkey Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Saudi Arabia Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. UAE Hot Flashes Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Global Sales Market Share of Hot Flashes Treatment by Type (2018-2029)
    Figure 52. Global Revenue Market Share of Hot Flashes Treatment by Type (2018-2029)
    Figure 53. Global Hot Flashes Treatment Price (US$/Unit) by Type (2018-2029)
    Figure 54. Global Sales Market Share of Hot Flashes Treatment by Application (2018-2029)
    Figure 55. Global Revenue Market Share of Hot Flashes Treatment by Application (2018-2029)
    Figure 56. Global Hot Flashes Treatment Price (US$/Unit) by Application (2018-2029)
    Figure 57. Hot Flashes Treatment Value Chain
    Figure 58. Hot Flashes Treatment Production Process
    Figure 59. Channels of Distribution (Direct Vs Distribution)
    Figure 60. Distributors Profiles
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart